Abstract:Panax ginseng and Panax notoginseng, two well-known medical plants with economic value, have a long history of use for managing various diseases in Asian countries. Accumulating clinical and experimental evidence suggests that notoginsenosides and ginsenosides, which are the major bioactive components of the plants, have a variety of beneficial effects on several types of disease, including metabolic, vascular, and central nervous system disease. Considerable attention has been focused on ginsenoside Rb1 derived from their common ownership as an anti-diabetic agent that can attenuate insulin resistance and various complications. Particularly, in vitro and in vivo models have suggested that ginsenoside Rb1 exerts various pharmacological effects on metabolic disorders, including attenuation of glycemia, hypertension, and hyperlipidemia, which depend on the modulation of oxidative stress, inflammatory response, autophagy, and anti-apoptosis effects. Regulation of these pathophysiological mechanisms can improve blood glucose and insulin resistance and protect against macrovascular/microvascular related complications. This review summarizes the pharmacological effects and mechanisms of action of ginsenoside Rb1 in the management of diabetes or diabetic complications. Moreover, a multi-target effect and mechanism analysis of its antidiabetic actions were performed to provide a theoretical basis for further pharmacological studies and new drug development for clinical treatment of type 2 diabetes. In conclusion, ginsenoside Rb1 exerts significant anti-obesity, anti-hyperglycemic, and anti-diabetic effects by regulating the effects of glycolipid metabolism and improving insulin and leptin sensitivities. All of these findings suggest ginsenoside Rb1 exerts protective effects on diabetes and diabetic complications by the regulation of mitochondrial energy metabolism, improving insulin resistance and alleviating the occurrence complications, which should be further explored. Hence, ginsenoside Rb1 may be developed as a potential anti-obesity, anti-hyperglycemic, and anti-diabetic agent with multi-target effects.

Therapeutic potential of ginsenosides on diabetes: From hypoglycemic mechanism to clinical trials

Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes

The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis

Ginseng and Diabetes: the Evidences from in Vitro, Animal and Human Studies

Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis

A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng

Exploring the mechanism of active components from ginseng to manage diabetes mellitus based on network pharmacology and molecular docking

Protective Effects and Therapeutics of Ginsenosides for Improving Endothelial Dysfunction: From Therapeutic Potentials, Pharmaceutical Developments to Clinical Trials

Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence

Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides.

Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications

The Molecular Mechanisms of Panax ginseng in Treating Type 2 Diabetes Mellitus: Network Pharmacology Analysis and Molecular Docking Validation

Mechanism of American Ginseng Against Type 2 Diabetes Mellitus Based on Network Pharmacology & Molecular Docking

Ginsenoside Rd Attenuated Hyperglycemia Via Akt Pathway and Modulated Gut Microbiota in Streptozotocin-Induced Diabetic Rats

Advance in Studies on Anti-Diabetic Mechanism of Gardeniae Fructus and Its Active Ingredient Geniposide

Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms

Research progress on the molecular mechanism of geniposide for diabetes and its complications treatment

Hypolipidemic effect and molecular mechanism of ginsenosides: a review based on oxidative stress

Antidiabetic Potential of Tea and Its Active Compounds: From Molecular Mechanism to Clinical Evidence

Ginsenoside Rg1 Improved Diabetes Through Regulating the Intestinal Microbiota in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes Rats.

Ginsenoside Rh1 Improves Type 2 Diabetic Nephropathy Through AMPK/PI3K/Akt-Mediated Inflammation and Apoptosis Signaling Pathway.